A citation-based method for searching scientific literature

Kristin Bergethon, Alice T Shaw, Sai-Hong Ignatius Ou, Ryohei Katayama, Christine M Lovly, Nerina T McDonald, Pierre P Massion, Christina Siwak-Tapp, Adriana Gonzalez, Rong Fang, Eugene J Mark, Julie M Batten, Haiquan Chen, Keith D Wilner, Eunice L Kwak, Jeffrey W Clark, David P Carbone, Hongbin Ji, Jeffrey A Engelman, Mari Mino-Kenudson, William Pao, A John Iafrate. J Clin Oncol 2012
Times Cited: 988



Alice T Shaw, Dong-Wan Kim, Kazuhiko Nakagawa, Takashi Seto, Lucio Crinó, Myung-Ju Ahn, Tommaso De Pas, Benjamin Besse, Benjamin J Solomon, Fiona Blackhall, Yi-Long Wu, Michael Thomas, Kenneth J O'Byrne, Denis Moro-Sibilot, D Ross Camidge, Tony Mok, Vera Hirsh, Gregory J Riely, Shrividya Iyer, Vanessa Tassell, Anna Polli, Keith D Wilner, Pasi A Jänne. N Engl J Med 2013
Times Cited: 2343




List of shared articles



Times cited

Systemic Therapy for Mutation-Driven NSCLC.
Lova Sun, Melina E Marmarelis, Corey J Langer. Semin Radiat Oncol 2021
0

Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
Nikolaj Frost, Petros Christopoulos, Diego Kauffmann-Guerrero, Jan Stratmann, Richard Riedel, Monica Schaefer, Jürgen Alt, Sylvia Gütz, Daniel C Christoph, Eckart Laack,[...]. Ther Adv Med Oncol 2021
2


Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
Kathleen Kerrigan, Xuechen Wang, Benjamin Haaland, Blythe Adamson, Shiven Patel, Sonam Puri, Wallace Akerley. Clin Lung Cancer 2021
0

Implementation of clinical sequencing for molecular profiling in patients with advanced cancer.
Tomoya Fukui, Kazuko Sakai, Jiichiro Sasaki, Mikiko Ishihara Kakegawa, Satoshi Igawa, Hisashi Mitsufuji, Masayuki Takeda, Takayuki Takahama, Kazuhiko Nakagawa, Kazuto Nishio,[...]. Cancer Biomark 2021
0

A Phase I Trial of the MET/ALK/ROS1 Inhibitor Crizotinib Combined with the VEGF Inhibitor Pazopanib in Patients with Advanced Solid Malignancies.
Sarina A Piha-Paul, Ecaterina E Dumbrava, Binoj C Nair, Wendy Xiong, Li Xu, Rosa Mostorino, Vivek Subbiah, Nizar Tannir, Siqing Fu, Aung Naing,[...]. Onco Targets Ther 2021
1

Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLC.
Sarah Waliany, Han Zhu, Heather Wakelee, Sukhmani K Padda, Millie Das, Kavitha Ramchandran, Nathaniel J Myall, Thomas Chen, Ronald M Witteles, Joel W Neal. J Thorac Oncol 2021
0

Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Vinayak Palve, Yi Liao, Lily L Remsing Rix, Uwe Rix. Semin Cancer Biol 2021
7


Analysis of metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutation.
Yu Chen, Juan Deng, Yu Liu, Hao Wang, Sha Zhao, Yayi He, Caicun Zhou. Ann Transl Med 2021
0


EZR-ROS1 fusion renal cell carcinoma mimicking urothelial carcinoma: report of a previously undescribed gene fusion in renal cell carcinoma.
Antic Tatjana, Melissa Y Tjota, Peter H O'Donnell, Scott E Eggener, Piyush K Agarwal, Rishikesh Haridas, Jeremy Segal, Peng Wang. Virchows Arch 2021
0

Immunotherapy in oncogene addicted non-small cell lung cancer.
Luke McLean, Jose Luis Leal, Benjamin J Solomon, Thomas John. Transl Lung Cancer Res 2021
0

First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly.
Tania Losanno, Cesare Gridelli. Curr Oncol Rep 2021
0

Precision Management of Advanced Non-Small Cell Lung Cancer.
Ching-Yao Yang, James Chih-Hsin Yang, Pan-Chyr Yang. Annu Rev Med 2020
24

Optimizing Mutation and Fusion Detection in NSCLC by Sequential DNA and RNA Sequencing.
Danielle Cohen, Liesbeth M Hondelink, Nienke Solleveld-Westerink, Sandra M Uljee, Dina Ruano, Anne-Marie Cleton-Jansen, Jan H von der Thüsen, S Rajen S Ramai, Pieter E Postmus, Jacob F Graadt van Roggen,[...]. J Thorac Oncol 2020
21